acquired
Stage
1
Investors
About
Amedrix is a German medical technology company that develops, produces, and distributes collagen-based implants for regenerative medicine, focusing on the repair of cartilage and bone defects.
Explore Amedrix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.